Oklahoma prosecutors compare J&J to drug ‘kingpin’; Biden unveils healthcare plan; Gilead increases stake in Galapagos.
Staying wholly owned by WPP would have limited ambitions, Kantar CEO says.
After its setback in the Oklahoma opioid trial, J&J should compromise rather than face judgment.
The company’s failed bid to have the Oklahoma opioid case tossed was followed this week by a reported criminal probe into its talcum baby powder.
Feds to pursue criminal investigation into J&J; 23andMe wants access to medical records alongside DNA; Another Alzheimer’s trial fails.
The coalition is made up of 12 eye-health pharma and biotech companies.
Researchers looked at the effectiveness of court-ordered anti-smoking campaigns paid for by the tobacco industry.
The sale valued Kantar at $4 billion.
CVS to expand health-focused stores; Reckitt Benckiser to pay $1.4 billion to end opioid probes; House committee discusses marijuana legalization.
Plus: People moves at Springer, Eversana and HealthNow New York.